The authors postulated that additional factors, including altered adipokine levels such as increased leptin and reduced adiponectin, and hyperinsulinemia might potentially have mediated the effects of obesity on BMD in diabetes. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.